Department of Medicine, UMass Chan Medical School, Worcester, MA, USA.
Department of Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Ann Med. 2023 Dec;55(1):526-532. doi: 10.1080/07853890.2022.2159516.
Early detection of AF is critical for stroke prevention. Several commercially available smartwatches are FDA cleared for AF detection. However, little is known about how patient-physician relationships affect patients' anxiety, activation, and health-related quality of life when prescribed smartwatch for AF detection.
Data were used from the Pulsewatch study (NCT03761394), which randomized adults (>50 years) with no contraindication to anticoagulation and a CHADS-VASc risk score ≥2 to receive a smartwatch-smartphone app dyad for AF monitoring vs. conventional monitoring with an ECG patch (Cardea Solo) and monitored participants for up to 45 days. The Perceived Efficacy in Patient-Physician Interactions survey was used to assess patient confidence in physician interaction at baseline with scores ≥45 indicating high perceived efficacy in patient-provider interactions. Generalized Anxiety Disorder-7 Scale, Consumer Health Activation Index, and Short-Form Health Survey were utilized to examine anxiety, patient activation, and physical and mental health status, at baseline, 14, and 44 days, respectively. We used mixed-effects repeated measures linear regression models to assess changes in psychosocial outcomes among smartwatch users in relation to self-reported efficacy in physician interaction over the study period.
A total of 93 participants (average age 64.1 ± 8.9 years; 43.0% female; 88.2% non-Hispanic white) were included in this analysis. At baseline, fifty-six (60%) participants reported high perceived efficacy in patient-physician interaction. In the fully adjusted models, high perceived efficacy (vs. low) at baseline was associated with greater patient activation and perceived mental health ( 12.0, -value <0.001; 3.39, -value <0.05, respectively). High perceived self-efficacy was not associated with anxiety or physical health status ( - 0.61, -value 0.46; 0.64, -value 0.77) among study participants.
Higher self-efficacy in patient-physician interaction was associated with higher patient activation and mental health status among stroke survivors using smartwatches. Furthermore, we found no association between anxiety and smartwatch prescription for AF in participants with high self-efficacy in patient-physician interaction. Efforts to improve self-efficacy in patient-physician interaction may improve patient activation and self-rated health and subsequently may lead to better clinical outcomes.KEY MESSAGESHigher self-efficacy in patient-physician interaction was associated with higher patient activation and mental health status among stroke survivors using smartwatches.No association between anxiety and smartwatch prescription for AF in participants with high self-efficacy in patient-physician interaction.Efforts to improve self-efficacy in patient-physician interaction may improve patient activation and self-rated health and subsequently may lead to better clinical outcomes.
房颤(AF)的早期检测对预防中风至关重要。有几种市售的智能手表已获得美国食品和药物管理局(FDA)批准可用于房颤检测。然而,对于因房颤而被开具智能手表进行检测的患者,医患关系如何影响其焦虑、积极性和健康相关生活质量,目前知之甚少。
本研究数据来自 Pulsewatch 研究(NCT03761394),该研究将无抗凝禁忌且 CHADS-VASc 风险评分≥2 的成年患者(>50 岁)随机分为接受智能手表-智能手机应用程序双联设备进行房颤监测组和接受心电图贴片(Cardea Solo)常规监测组,监测参与者最长达 45 天。使用医患互动感知效能调查来评估患者在基线时对医患互动的信心,得分≥45 分表示患者对医患互动的感知效能较高。使用广泛性焦虑障碍 7 项量表、消费者健康激活指数和健康调查简表分别在基线、第 14 天和第 44 天评估焦虑、患者积极性以及身体和心理健康状况。我们使用混合效应重复测量线性回归模型来评估研究期间智能手表使用者的心理社会结局变化与自我报告的医患互动效能之间的关系。
共有 93 名参与者(平均年龄 64.1±8.9 岁;43.0%为女性;88.2%为非西班牙裔白人)纳入本分析。基线时,56(60%)名参与者报告医患互动感知效能较高。在完全调整的模型中,基线时感知效能较高(与较低相比)与患者积极性和感知心理健康状况改善相关(12.0,-值<0.001;3.39,-值<0.05)。在研究参与者中,感知效能较高与焦虑或身体健康状况无关(-0.61,-值 0.46;0.64,-值 0.77)。
使用智能手表的中风幸存者中,医患互动感知效能较高与患者积极性和心理健康状况较高相关。此外,我们发现,在感知效能较高的患者中,焦虑与房颤的智能手表处方之间没有关联。提高医患互动感知效能的努力可能会改善患者积极性和自我评估的健康状况,从而可能带来更好的临床结局。
使用智能手表的中风幸存者中,医患互动感知效能较高与患者积极性和心理健康状况较高相关。
在感知效能较高的患者中,焦虑与房颤的智能手表处方之间没有关联。
提高医患互动感知效能的努力可能会改善患者积极性和自我评估的健康状况,从而可能带来更好的临床结局。